{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T06:44:19Z","timestamp":1774680259938,"version":"3.50.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,1,22]],"date-time":"2020-01-22T00:00:00Z","timestamp":1579651200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,1,22]],"date-time":"2020-01-22T00:00:00Z","timestamp":1579651200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Malar J"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>The Sustainable Development Goals (SDG) call for increased gender equity and reduction in malaria-related mortality and morbidity. <jats:italic>Plasmodium vivax<\/jats:italic> infections in pregnancy are associated with maternal anaemia and increased adverse perinatal outcomes. Providing radical cure for women with 8-aminoquinolines (e.g., primaquine) is hindered by gender-specific complexities.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Case presentation<\/jats:title>\n<jats:p>A symptomatic episode of vivax malaria at 18\u00a0weeks of gestation in a primigravid woman was associated with maternal anaemia, a recurrent asymptomatic <jats:italic>P. vivax<\/jats:italic> episode, severe intra-uterine growth restriction with no other identifiable cause and induction to reduce the risk of stillbirth. At 5\u00a0months postpartum a qualitative glucose-6-phosphate dehydrogenase (G6PD) point-of-care test was normal and radical cure with primaquine was prescribed to the mother. A 33% fractional decrease in haematocrit on day 7 of primaquine led to further testing which showed intermediate phenotypic G6PD activity; the G6PD genotype could not be identified. Her infant daughter was well throughout maternal treatment and found to be heterozygous for Mahidol variant.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusion<\/jats:title>\n<jats:p>Adverse effects of vivax malaria in pregnancy, ineligibility of radical cure for pregnant and postpartum women, and difficulties in diagnosing intermediate levels of G6PD activity multiplied morbidity in this woman. Steps towards meeting the SDG include prevention of malaria in pregnancy, reducing unnecessary exclusion of women from radical cure, and accessible quantitative G6PD screening in <jats:italic>P. vivax<\/jats:italic>-endemic settings.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s12936-020-3123-1","type":"journal-article","created":{"date-parts":[[2020,1,22]],"date-time":"2020-01-22T16:02:55Z","timestamp":1579708975000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Vivax malaria in pregnancy and lactation: a long way to health equity"],"prefix":"10.1186","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9739-2084","authenticated-orcid":false,"given":"Tobias","family":"Brummaier","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary Ellen","family":"Gilder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gornpan","family":"Gornsawun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cindy S.","family":"Chu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Germana","family":"Bancone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mupawjay","family":"Pimanpanarak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kesinee","family":"Chotivanich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fran\u00e7ois","family":"Nosten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rose","family":"McGready","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,1,22]]},"reference":[{"key":"3123_CR1","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s12936-015-1039-y","volume":"15","author":"GM Diiro","year":"2016","unstructured":"Diiro GM, Affognon HD, Muriithi BW, Wanja SK, Mbogo C, Mutero C. The role of gender on malaria preventive behaviour among rural households in Kenya. Malar J. 2016;15:14.","journal-title":"Malar J."},{"key":"3123_CR2","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1136\/jech.57.4.254","volume":"57","author":"P Braveman","year":"2003","unstructured":"Braveman P, Gruskin S. Defining equity in health. J Epidemiol Community Health. 2003;57:254\u20138.","journal-title":"J Epidemiol Community Health"},{"key":"3123_CR3","unstructured":"WHO. World malaria report 2018. Geneva: World Health Organization, 2018. https:\/\/apps.who.int\/iris\/handle\/10665\/275867."},{"key":"3123_CR4","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s12916-017-0863-z","volume":"15","author":"KA Moore","year":"2017","unstructured":"Moore KA, Fowkes FJI, Wiladphaingern J, Wai NS, Paw MK, Pimanpanarak M, et al. Mediation of the effect of malaria in pregnancy on stillbirth and neonatal death in an area of low transmission: observational data analysis. BMC Med. 2017;15:98.","journal-title":"BMC Med."},{"key":"3123_CR5","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/s12916-017-0877-6","volume":"15","author":"KA Moore","year":"2017","unstructured":"Moore KA, Simpson JA, Wiladphaingern J, Min AM, Pimanpanarak M, Paw MK, et al. Influence of the number and timing of malaria episodes during pregnancy on prematurity and small-for-gestational-age in an area of low transmission. BMC Med. 2017;15:117.","journal-title":"BMC Med."},{"key":"3123_CR6","doi-asserted-by":"publisher","first-page":"e0006440","DOI":"10.1371\/journal.pntd.0006440","volume":"12","author":"J Watson","year":"2018","unstructured":"Watson J, Taylor WRJ, Bancone G, Chu CS, Jittamala P, White NJ. Implications of current therapeutic restrictions for primaquine and tafenoquine in the radical cure of vivax malaria. PLoS Negl Trop Dis. 2018;12:e0006440.","journal-title":"PLoS Negl Trop Dis."},{"key":"3123_CR7","unstructured":"WHO. Guidelines for the treatment of malaria. 3rd Edn. Geneva: World Health Organization, 2015. http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK294440\/."},{"key":"3123_CR8","doi-asserted-by":"publisher","first-page":"e23061","DOI":"10.7554\/eLife.23061","volume":"6","author":"J Watson","year":"2017","unstructured":"Watson J, Taylor WR, Menard D, Kheng S, White NJ. Modelling primaquine-induced haemolysis in G6PD deficiency. ELife. 2017;6:e23061.","journal-title":"ELife."},{"key":"3123_CR9","unstructured":"Recht J, Ashley EA, White NJ. Safety of 8-aminoquinoline antimalarial medicines. Geneva: World Health Organization, 2014. http:\/\/www.who.int\/malaria\/publications\/atoz\/9789241506977\/en\/."},{"key":"3123_CR10","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1186\/1475-2875-13-418","volume":"13","author":"EA Ashley","year":"2014","unstructured":"Ashley EA, Recht J, White NJ. Primaquine: the risks and the benefits. Malar J. 2014;13:418.","journal-title":"Malar J."},{"key":"3123_CR11","doi-asserted-by":"publisher","first-page":"e1002224","DOI":"10.1371\/journal.pmed.1002224","volume":"14","author":"CS Chu","year":"2017","unstructured":"Chu CS, Bancone G, Moore KA, Win HH, Thitipanawan N, Po C, et al. Haemolysis in G6PD heterozygous females treated with primaquine for Plasmodium vivax malaria: a nested cohort in a trial of radical curative regimens. PLoS Med. 2017;14:e1002224.","journal-title":"PLoS Med."},{"key":"3123_CR12","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1186\/1475-2875-9-308","volume":"9","author":"R Takeuchi","year":"2010","unstructured":"Takeuchi R, Lawpoolsri S, Imwong M, Kobayashi J, Kaewkungwal J, Pukrittayakamee S, et al. Directly-observed therapy (DOT) for the radical 14-day primaquine treatment of Plasmodium vivax malaria on the Thai\u2013Myanmar border. Malar J. 2010;9:308.","journal-title":"Malar J."},{"key":"3123_CR13","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1056\/NEJMe1816383","volume":"380","author":"NJ White","year":"2019","unstructured":"White NJ. Tafenoquine\u2014a radical improvement? N Engl J Med. 2019;380:285\u20136.","journal-title":"N Engl J Med"},{"key":"3123_CR14","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1073\/pnas.48.1.9","volume":"48","author":"E Beutler","year":"1962","unstructured":"Beutler E, Yeh M, Fairbanks VF. The normal human female as a mosaic of X-chromosome activity: studies using the gene for G-6-PD-deficiency as a marker. Proc Natl Acad Sci USA. 1962;48:9\u201316.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3123_CR15","doi-asserted-by":"publisher","first-page":"e1002992","DOI":"10.1371\/journal.pmed.1002992","volume":"16","author":"B Ley","year":"2019","unstructured":"Ley B, Winasti Satyagraha A, Rahmat H, von Fricken ME, Douglas NM, Pfeffer DA, et al. Performance of the Access Bio\/CareStart rapid diagnostic test for the detection of glucose-6-phosphate dehydrogenase deficiency: a\u00a0systematic review and meta-analysis. PLoS Med. 2019;16:e1002992.","journal-title":"PLoS Med."},{"key":"3123_CR16","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1093\/inthealth\/ihy060","volume":"11","author":"GJ Domingo","year":"2019","unstructured":"Domingo GJ, Advani N, Satyagraha AW, Sibley CH, Rowley E, Kalnoky M, et al. Addressing the gender-knowledge gap in glucose-6-phosphate dehydrogenase deficiency: challenges and opportunities. Int Health. 2019;11:7\u201314.","journal-title":"Int Health."},{"key":"3123_CR17","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1111\/bjh.12665","volume":"164","author":"L Luzzatto","year":"2014","unstructured":"Luzzatto L, Seneca E. G6PD deficiency: a classic example of pharmacogenetics with on-going clinical implications. Br J Haematol. 2014;164:469\u201380.","journal-title":"Br J Haematol"},{"key":"3123_CR18","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1186\/1475-2875-12-391","volume":"12","author":"GJ Domingo","year":"2013","unstructured":"Domingo GJ, Satyagraha AW, Anvikar A, Baird K, Bancone G, Bansil P, et al. G6PD testing in support of treatment and elimination of malaria: recommendations for evaluation of G6PD tests. Malar J. 2013;12:391.","journal-title":"Malar J."},{"key":"3123_CR19","doi-asserted-by":"publisher","first-page":"e0196716","DOI":"10.1371\/journal.pone.0196716","volume":"13","author":"G Bancone","year":"2018","unstructured":"Bancone G, Gornsawun G, Chu CS, Porn P, Pal S, Bansil P, et al. Validation of the quantitative point-of-care CareStart biosensor for assessment of G6PD activity in venous blood. PLoS ONE. 2018;13:e0196716.","journal-title":"PLoS ONE"},{"key":"3123_CR20","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1186\/s13104-018-3964-7","volume":"11","author":"MS Alam","year":"2018","unstructured":"Alam MS, Kibria MG, Jahan N, Price RN, Ley B. Spectrophotometry assays to determine G6PD activity from Trinity Biotech and Pointe Scientific G6PD show good correlation. BMC Res Notes. 2018;11:855.","journal-title":"BMC Res Notes."},{"key":"3123_CR21","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/s12936-016-1169-x","volume":"15","author":"WHO Malaria Policy Advisory Committee and Secretariat","year":"2016","unstructured":"WHO Malaria Policy Advisory Committee and Secretariat. Malaria Policy Advisory Committee to the WHO: conclusions and recommendations of eighth biannual meeting (September 2015). Malar J. 2016;15:117.","journal-title":"Malar J."},{"key":"3123_CR22","doi-asserted-by":"publisher","first-page":"e57890","DOI":"10.1371\/journal.pone.0057890","volume":"8","author":"ME Boel","year":"2013","unstructured":"Boel ME, Rijken MJ, Leenstra T, Phyo AP, Pimanpanarak M, Keereecharoen NL, et al. Malaria in the post-partum period; a prospective cohort study. PLoS ONE. 2013;8:e57890.","journal-title":"PLoS ONE"},{"key":"3123_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-018-07882-8","volume":"10","author":"AR Taylor","year":"2019","unstructured":"Taylor AR, Watson JA, Chu CS, Puaprasert K, Duanguppama J, Day NPJ, et al. Resolving the cause of recurrent Plasmodium vivax malaria probabilistically. Nat Commun. 2019;10:1\u201311.","journal-title":"Nat Commun."},{"key":"3123_CR24","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1093\/cid\/ciy319","volume":"67","author":"CS Chu","year":"2018","unstructured":"Chu CS, Phyo AP, Lwin KM, Win HH, San T, Aung AA, et al. Comparison of the cumulative efficacy and safety of qhloroquine, artesunate, and chloroquine-primaquine in Plasmodium vivax malaria. Clin Infect Dis. 2018;67:1543\u20139.","journal-title":"Clin Infect Dis"},{"key":"3123_CR25","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1016\/S0140-6736(98)09247-2","volume":"354","author":"F Nosten","year":"1999","unstructured":"Nosten F, McGready R, Simpson JA, Thwai KL, Balkan S, Cho T, et al. Effects of Plasmodium vivax malaria in pregnancy. Lancet. 1999;354:546\u20139.","journal-title":"Lancet"},{"key":"3123_CR26","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/S0140-6736(14)60932-6","volume":"384","author":"J Villar","year":"2014","unstructured":"Villar J, Cheikh Ismail L, Victora CG, Ohuma EO, Bertino E, Altman DG, et al. International standards for newborn weight, length, and head circumference by gestational age and sex: the Newborn Cross-Sectional Study of the Intergrowth-21st Project. Lancet. 2014;384:857\u201368.","journal-title":"Lancet"},{"key":"3123_CR27","doi-asserted-by":"publisher","first-page":"818","DOI":"10.4269\/ajtmh.14-0696","volume":"92","author":"G Bancone","year":"2015","unstructured":"Bancone G, Chu CS, Chowwiwat N, Somsakchaicharoen R, Wilaisrisak P, Charunwatthana P, et al. Suitability of capillary blood for quantitative assessment of G6PD activity and performances of G6PD point-of-care tests. Am J Trop Med Hyg. 2015;92:818\u201324.","journal-title":"Am J Trop Med Hyg"},{"key":"3123_CR28","doi-asserted-by":"publisher","first-page":"72","DOI":"10.12688\/wellcomeopenres.12338.1","volume":"2","author":"G Bancone","year":"2017","unstructured":"Bancone G, Gilder ME, Chowwiwat N, Gornsawun G, Win E, Cho WW, et al. Prevalences of inherited red blood cell disorders in pregnant women of different ethnicities living along the Thailand\u2013Myanmar border. Wellcome Open Res. 2017;2:72.","journal-title":"Wellcome Open Res."},{"key":"3123_CR29","doi-asserted-by":"publisher","first-page":"e116063","DOI":"10.1371\/journal.pone.0116063","volume":"9","author":"G Bancone","year":"2014","unstructured":"Bancone G, Chu CS, Somsakchaicharoen R, Chowwiwat N, Parker DM, Charunwatthana P, et al. Characterization of G6PD genotypes and phenotypes on the northwestern Thailand\u2013Myanmar border. PLoS ONE. 2014;9:e116063.","journal-title":"PLoS ONE"},{"key":"3123_CR30","doi-asserted-by":"publisher","first-page":"e28357","DOI":"10.1371\/journal.pone.0028357","volume":"6","author":"S Kim","year":"2011","unstructured":"Kim S, Nguon C, Guillard B, Duong S, Chy S, Sum S, et al. Performance of the CareStart G6PD deficiency screening test, a point-of-care diagnostic for primaquine therapy screening. PLoS ONE. 2011;6:e28357.","journal-title":"PLoS ONE"},{"key":"3123_CR31","doi-asserted-by":"publisher","first-page":"2608","DOI":"10.1182\/blood-2004-06-2135","volume":"104","author":"T Efferth","year":"2004","unstructured":"Efferth T, Bachli EB, Schwarzl SM, Goede JS, West C, Smith JC, et al. Glucose-6-phosphate dehydrogenase (G6PD) deficiency-type Zurich: a splice site mutation as an uncommon mechanism producing enzyme deficiency. Blood. 2004;104:2608.","journal-title":"Blood"},{"key":"3123_CR32","doi-asserted-by":"publisher","first-page":"2550","DOI":"10.1016\/S0140-6736(19)30651-8","volume":"393","author":"GR Gupta","year":"2019","unstructured":"Gupta GR, Oomman N, Grown C, Conn K, Hawkes S, Shawar YR, et al. Gender equality and gender norms: framing the opportunities for health. Lancet. 2019;393:2550\u201362.","journal-title":"Lancet"},{"key":"3123_CR33","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1186\/s12916-019-1386-6","volume":"17","author":"RJ Commons","year":"2019","unstructured":"Commons RJ, Simpson JA, Thriemer K, Chu CS, Douglas NM, Abreha T, et al. The haematological consequences of Plasmodium vivax malaria after chloroquine treatment with and without primaquine: a WorldWide Antimalarial Resistance Network systematic review and individual patient data meta-analysis. BMC Med. 2019;17:151.","journal-title":"BMC Med."},{"key":"3123_CR34","doi-asserted-by":"publisher","first-page":"e40244","DOI":"10.1371\/journal.pone.0040244","volume":"7","author":"R McGready","year":"2012","unstructured":"McGready R, Boel M, Rijken MJ, Ashley EA, Cho T, Moo O, et al. Effect of early detection and treatment on malaria related maternal mortality on the north-western border of Thailand 1986\u20132010. PLoS ONE. 2012;7:e40244.","journal-title":"PLoS ONE"},{"issue":"1","key":"3123_CR35","doi-asserted-by":"publisher","first-page":"73","DOI":"10.4269\/ajtmh.18-0135","volume":"99","author":"A Pincelli","year":"2018","unstructured":"Pincelli A, Neves PAR, Louren\u00e7o BH, Corder RM, Malta MB, Sampaio-Silva J, et al. The hidden burden of Plasmodium vivax malaria in pregnancy in the Amazon: an observational study in Northwestern Brazil. Am J Trop Med Hyg 2018;99(1):73-83","journal-title":"Am J Trop Med Hyg"},{"key":"3123_CR36","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1093\/cid\/ciy235","volume":"67","author":"ME Gilder","year":"2018","unstructured":"Gilder ME, Hanpithakphong W, Hoglund RM, Tarning J, Win HH, Hilda N, et al. Primaquine pharmacokinetics in lactating women and breastfed infant exposures. Clin Infect Dis. 2018;67:1000\u20137.","journal-title":"Clin Infect Dis"},{"key":"3123_CR37","unstructured":"WHO. Global technical strategy for malaria 2016\u20132030. Geneva:World Health Organization, 2015. http:\/\/www.who.int\/malaria\/areas\/global_technical_strategy\/en\/."},{"key":"3123_CR38","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1097\/AOG.0b013e3181c2bde8","volume":"114","author":"M Abbassi-Ghanavati","year":"2009","unstructured":"Abbassi-Ghanavati M, Greer LG, Cunningham FG. Pregnancy and laboratory studies: a reference table for clinicians. Obstet Gynecol. 2009;114:1326\u201331.","journal-title":"Obstet Gynecol"}],"container-title":["Malaria Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-020-3123-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12936-020-3123-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-020-3123-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,21]],"date-time":"2021-01-21T00:17:54Z","timestamp":1611188274000},"score":1,"resource":{"primary":{"URL":"https:\/\/malariajournal.biomedcentral.com\/articles\/10.1186\/s12936-020-3123-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,22]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["3123"],"URL":"https:\/\/doi.org\/10.1186\/s12936-020-3123-1","relation":{},"ISSN":["1475-2875"],"issn-type":[{"value":"1475-2875","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,22]]},"assertion":[{"value":"17 December 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient for publication of this case report. A copy of the written consent is available for review by the Editor-in-Chief of this journal.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"40"}}